Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

This early-stage study tested a new drug called HDM1005 in 65 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single shot. The study also looked at changes in weight and other health markers. The goal is t…

This early-stage study tested a new injection called HDM1005 in 40 overweight or obese adults. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored side effects and drug levels …

This study tested a cream called roflumilast (ZORYVE®) in 354 people aged 6 and older with mild to moderate eczema. Participants applied the cream once daily for 4 weeks. The goal was to see if the cream could clear or nearly clear the skin rash better than a cream with no active…